Navigation Links
Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board
Date:2/5/2010

CRANBURY, N.J., Feb. 5 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) announced today that its Board of Directors has elected John F. Crowley as Chairman of the Board in addition to his current role as Chief Executive Officer (CEO), effective immediately.  Mr. Crowley will succeed Donald J. Hayden, Jr., who will become the Lead Independent Director of the Board.

"The Board's decision to elect Mr. Crowley as Chairman of the Board reflects our confidence in his leadership and vision for Amicus.  Additionally, the Board recognized the value of the strong independent leadership provided by Mr. Hayden during his tenure as Chairman which will be preserved through his appointment as Lead Independent Director," stated Alexander Barkas, Ph.D., Amicus Board of Director and Member of Governance and Nominating Committee.

In his role as Chairman of the Board, Mr. Crowley will lead the Board's efforts in overseeing the development and implementation of the Company's strategic vision.  

As Lead Independent Director, Mr. Hayden will be responsible for, among other things, leading executive sessions of the Board's independent directors, advising the independent board committee chairs in fulfilling their responsibilities to the Board, assisting the Board and the Company's Officers in complying with Amicus' governance guidelines and overseeing the process of evaluating, developing and compensating the CEO.  A copy of the Lead Independent Director Charter describing in full Mr. Hayden's roles and responsibilities is available on the Amicus website at

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2014)... NY (PRWEB) July 20, 2014 ... custom quartz glass optics, and spectrophotometer calibration ... these years, NSG has released many products that ... successful product has been their solid-state calibration standards. ... liquid standards since their release in 2008. ...
(Date:7/18/2014)... 2014 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced ... and operating results on Tuesday, August 5, 2014, before ... a conference call and simultaneous webcast at 8:30 AM ... InformationTo access this call, dial (888) 660-6127 (U.S.) or ... be accessed from the ,Events and Presentations, page of ...
(Date:7/18/2014)... Researchers at the University of Illinois at Urbana-Champaign ... pillar-bowtie nanoantennas (pBNAs) can be used like traditional ... are much smaller than the wavelength of light ... red light). A standard optical microscope acts as ... film. , "Unlike conventional photographic film, the effect ...
(Date:7/18/2014)... Reflecting the importance of the evolution of ... Rankin, the founder and president of Customized Real ... a fresh new approach to the firm’s branding. , ... influence the success of his or her commercial clients have ... of the first in this market to fully embrace the ...
Breaking Biology Technology:How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 2How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 3'Nanocamera' takes pictures at distances smaller than light's own wavelength 2LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding 2
... N.J., Nov. 4 Cambrex,Corporation (NYSE: CBM ) reports third ... (Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO ), -- Sales increased ... third quarter 2007. -- Adjusted EBITDA for the quarter was ... $9.7 million last year. -- Debt, net of cash was ...
... - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced ... pursue a pivotal (Phase II/III) randomized trial ... refractory,patients with head and neck cancers. The ... by the Company,s Board of Directors from ...
... Md., Nov. 4 PharmAthene, Inc.,(NYSE Alternext US: ... and chemical threats, announced today,that David P. Wright, ... at the Rodman and Renshaw 10th Annual Healthcare ... beginning at 2:25 p.m. E.T. in the,Holmes II ...
Cached Biology Technology:Cambrex Reports Third Quarter 2008 Results 2Cambrex Reports Third Quarter 2008 Results 3Cambrex Reports Third Quarter 2008 Results 4Cambrex Reports Third Quarter 2008 Results 5Cambrex Reports Third Quarter 2008 Results 6Cambrex Reports Third Quarter 2008 Results 7Cambrex Reports Third Quarter 2008 Results 8Cambrex Reports Third Quarter 2008 Results 9Cambrex Reports Third Quarter 2008 Results 10Cambrex Reports Third Quarter 2008 Results 11Cambrex Reports Third Quarter 2008 Results 12Cambrex Reports Third Quarter 2008 Results 13Cambrex Reports Third Quarter 2008 Results 14Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial 2
(Date:7/21/2014)... Growers of annual bedding plant seedlings or plugs ... a large stem diameter and high root dry ... during shipping and transplant. To achieve these desirable ... on supplemental lighting from high-pressure sodium lamps during ... diodes (LEDs) can give greenhouse growers other lighting ...
(Date:7/21/2014)... their cells are stressed when facing temperature extremes. Worse ... in the cell are slowed down more than others, ... of whack. Yet, those cells manage to keep their ... Rochester and the European Molecular Biology Laboratory have found ... of proteins is a key process in all cells, ...
(Date:7/20/2014)... A study of 473 sets of twins followed since ... of 24-month-old identical twins had language delay compared to ... the rate of late language emergence of single-born children. ... , The results of the study were published in ... Hearing Research . , University of Kansas Distinguished ...
Breaking Biology News(10 mins):LEDs shine in bedding plant production study 2When temperatures get cold, newly-discovered process helps fruit flies cope 2Large twin study suggests that language delay due more to nature than nurture 2Large twin study suggests that language delay due more to nature than nurture 3
... things that exist underground, plant roots are out-of-sight and ... plant parts are more familiar, plant roots are equally ... crop, and dazzling ornamental lies a root system that ... for plants, extract water and nutrients from soil, and ...
... Since the terrorist attacks of 2001, the Bureau of ... water and power to millions of people, has invested ... protect its facilities and personnel, says a new report ... better communication among security staff, regional and area office ...
... WI, AUGUST 18, 2008 Serpentine soils contain highly ... farming. Successful management of serpentine soils requires accurate measurement ... in the Soil Science Society of America Journal ... accurately measure calcium content in serpentine soils. To ...
Cached Biology News:Getting to the root of the matter 2National Research Council report on security at federally managed dams 2National Research Council report on security at federally managed dams 3